Genome wide association studies for diabetes: perspective on results and challenges

Recent results of genome wide association study (GWAS) for diabetes genes, while reaching impressive technical milestones and implicating new findings for research, have been uniformly disappointing in terms of immediate clinical utility. The relative risk associated with any of the newly reported genetic loci, or even considering all of them together, is far less than simply that which can be obtained by taking a history and a physical exam. For type 2 diabetes (T2D), GWAS have implicated novel pathways, supported previously known associations, and highlighted the importance of the beta cell and insulin secretion. Monogenic forms of diabetes, on the other hand, continue to yield interesting insights into genes controlling human beta cell function but most cases of monogenic diabetes are simply not diagnosed. Here, we briefly review recent results related to type 1, type 2 and maturity onset diabetes of youth (MODY) diabetes and suggest that future studies emphasizing quantitative traits are likely to yield even more insights.

[1]  L. Peltonen,et al.  HLA haplotypes in Type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus , 1992, Diabetologia.

[2]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[3]  Christian Gieger,et al.  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.

[4]  P. McKeigue,et al.  Genome-wide association study of type 2 diabetes in a sample from Mexico City and a meta-analysis of a Mexican-American sample from Starr County, Texas , 2011, Diabetologia.

[5]  C. Graver.  Statistical Genetics: Gene Mapping Through Linkage and Association , 2008 .

[6]  E. Zeggini,et al.  A new era for Type 2 diabetes genetics , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[7]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[8]  P. Visscher,et al.  Five years of GWAS discovery. , 2012, American journal of human genetics.

[9]  D. Nicolae,et al.  Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals , 2011, Diabetologia.

[10]  P. Poulsen,et al.  Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance – a population-based twin study , 1999, Diabetologia.

[11]  Philippe Froguel,et al.  Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight , 2010, Nature Genetics.

[12]  Chaeyoung Lee,et al.  Association of glycosylated hemoglobin with the gene encoding CDKAL1 in the Korean Association Resource (KARE) study , 2012, Human mutation.

[13]  G I Bell,et al.  Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. , 2001, The New England journal of medicine.

[14]  Lu Qi,et al.  Variant of Transcription Factor 7-Like 2 (TCF7L2) Gene and the Risk of Type 2 Diabetes in Large Cohorts of U.S. Women and Men , 2006, Diabetes.

[15]  C. Amos.  Successful design and conduct of genome-wide association studies. , 2007, Human molecular genetics.

[16]  Geoffrey B. Nilsen,et al.  Whole-Genome Patterns of Common DNA Variation in Three Human Populations , 2005, Science.

[17]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[18]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[19]  A. Bradwell,et al.  Identification of susceptibility loci for Type 1 (insulin-dependent) diabetes by trans-racial gene mapping , 1990, Diabetologia.

[20]  Jeffrey Ross-Ibarra,et al.  Genetic Data Analysis II. Methods for Discrete Population Genentic Data , 2002 .

[21]  E S Lander,et al.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. , 2000, Nature genetics.

[22]  P. Donnelly,et al.  Designing Genome-Wide Association Studies: Sample Size, Power, Imputation, and the Choice of Genotyping Chip , 2009, PLoS genetics.

[23]  M. McCarthy,et al.  Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes , 2007, Science.

[24]  A. Favier,et al.  Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. , 2004, Diabetes.

[25]  Ingo Ruczinski,et al.  Hypothesis-driven candidate gene association studies: practical design and analytical considerations. , 2009, American journal of epidemiology.

[26]  F. Collins,et al.  The HapMap and genome-wide association studies in diagnosis and therapy. , 2009, Annual review of medicine.

[27]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.

[28]  Y. Taniguchi,et al.  Dual Functions of ASCIZ in the DNA Base Damage Response and Pulmonary Organogenesis , 2010, PLoS genetics.

[29]  G. Eisenbarth,et al.  Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. , 1990, Annual review of immunology.

[30]  J. Florez,et al.  The genetics of type 2 diabetes: what have we learned from GWAS? , 2010, Annals of the New York Academy of Sciences.

[31]  F. Collins,et al.  The Human Genome Project: Lessons from Large-Scale Biology , 2003, Science.

[32]  Steven Wiltshire,et al.  Association Analysis of 6,736 U.K. Subjects Provides Replication and Confirms TCF7L2 as a Type 2 Diabetes Susceptibility Gene With a Substantial Effect on Individual Risk , 2006, Diabetes.

[33]  D. Dries.  STATISTICAL GENETICS: GENE MAPPING THROUGH LINKAGE AND ASSOCIATION , 2008 .

[34]  Inês Barroso,et al.  Genome-wide association studies and type 2 diabetes. , 2011, Briefings in functional genomics.

[35]  E. Gamazon,et al.  Genetic risk factors for type 2 diabetes: a trans-regulatory genetic architecture? , 2012, American journal of human genetics.

[36]  M. McCarthy,et al.  Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. , 2003, Diabetes.

[37]  L. Peltonen,et al.  Classical twin studies and beyond , 2002, Nature Reviews Genetics.

[38]  D. Goldstein,et al.  Uncovering the roles of rare variants in common disease through whole-genome sequencing , 2010, Nature Reviews Genetics.

[39]  H. Stefánsson,et al.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.

[40]  K. Narayan,et al.  Clinical risk factors, DNA variants, and the development of type 2 diabetes. , 2009, The New England journal of medicine.

[41]  A. Scheinfeld,et al.  Women and men , 1945 .

[42]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[43]  L. Scott,et al.  What Will Diabetes Genomes Tell Us? , 2012, Current Diabetes Reports.

[44]  S. Maeda,et al.  Genetics of type 2 diabetes: the GWAS era and future perspectives [Review]. , 2011, Endocrine journal.

[45]  Inês Barroso,et al.  Variants in MTNR1B influence fasting glucose levels , 2009, Nature Genetics.

[46]  G. Abecasis,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.

[47]  J. Petrie,et al.  Implications of genome wide association studies for the understanding of type 2 diabetes pathophysiology. , 2011, Biochemical pharmacology.

[48]  J. Gulcher,et al.  Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. , 2003, American journal of human genetics.

[49]  B. Stranger,et al.  Progress and Promise of Genome-Wide Association Studies for Human Complex Trait Genetics , 2011, Genetics.

[50]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[51]  R. D'Agostino,et al.  Genotype score in addition to common risk factors for prediction of type 2 diabetes. , 2008, The New England journal of medicine.

[52]  B. Neale.  Statistical genetics : gene mapping through linkage and association , 2007 .

[53]  L. Groop,et al.  Metabolic Consequences of a Family History of NIDDM (The Botnia Study): Evidence for Sex-Specific Parental Effects , 1996, Diabetes.

[54]  T. Hudson,et al.  A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.

[55]  Simon C. Potter,et al.  A Genome-Wide Association Search for Type 2 Diabetes Genes in African Americans , 2012, PLoS ONE.

[56]  Marcia M. Nizzari,et al.  Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.

[57]  Dharambir K Sanghera,et al.  Type 2 Diabetes Genetics: Beyond GWAS. , 2012, Journal of diabetes & metabolism.

[58]  R. Wu,et al.  Designs for linkage analysis and association studies of complex diseases. , 2010, Methods in molecular biology.

[59]  N. Cox,et al.  Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWAS , 2010, PLoS genetics.

[60]  Tom H. Lindner,et al.  Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus , 2000, Nature Genetics.

[61]  J. Aerts,et al.  Exome Sequencing and Genetic Testing for MODY , 2012, PloS one.

[62]  D. Posthuma,et al.  Single Locus Association Models , 2007 .